Six-month changes in ghrelin and glucagon-like peptide-1 with weight loss are unrelated to long-term weight regain in obese older adults

被引：0
|
作者：
Jared J. Rejeski
Jason Fanning
Barbara J. Nicklas
W. Jack Rejeski
机构：
[1] Department of Internal Medicine,Department of Health & Exercise Science
[2] Section on Gastroenterology,undefined
[3] Wake Forest School of Medicine,undefined
[4] Wake Forest University,undefined
[5] Department of Internal Medicine,undefined
[6] Section on Gerontology and Geriatric Medicine,undefined
[7] Wake Forest School of Medicine,undefined
来源：
International Journal of Obesity | 2021年 / 45卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：888 / 894
页数：6
相关论文
共 50 条
  • [31] Glucagon-like peptide-1 release and satiety after a nutrient challenge in normal-weight and obese subjects
    Adam, TCM
    Westerterp-Plantenga, MS
    BRITISH JOURNAL OF NUTRITION, 2005, 93 (06) : 845 - 851
  • [32] Peripheral versus central effects of glucagon-like peptide-1 receptor agonists on satiety and body weight loss in Zucker obese rats
    de Fonseca, FR
    Navarro, M
    Alvarez, E
    Roncero, I
    Chowen, JA
    Maestre, O
    Gómez, R
    Muñoz, RM
    Eng, J
    Blázquez, E
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2000, 49 (06): : 709 - 717
  • [33] Sustained Weight Loss After Treatment With a Glucagon-Like Peptide-1 Receptor Agonist in an Obese Patient With Schizophrenia and Type 2 Diabetes
    Ishoy, Pelle L.
    Knop, Filip K.
    Vilsboll, Tina
    Glenthoj, Birte Y.
    Ebdrup, Bjorn H.
    AMERICAN JOURNAL OF PSYCHIATRY, 2013, 170 (06): : 681 - 682
  • [34] Compounded glucagon-like peptide-1 receptor agonists for weight loss: the direct-to-consumer market in Colorado
    Distefano, Michael J.
    Dardouri, Mouna
    Moore, Gina D.
    Saseen, Joseph J.
    Nair, Kavita V.
    JOURNAL OF PHARMACEUTICAL POLICY AND PRACTICE, 2025, 18 (01)
  • [35] Is it Time to Expand Glucagon-like Peptide-1 Receptor Agonist Use for Weight Loss in Patients Without Diabetes?
    Wendy H. Updike
    Olivia Pane
    Rachel Franks
    Faizah Saber
    Farah Abdeen
    Derek D. Balazy
    Nicholas W. Carris
    Drugs, 2021, 81 : 881 - 893
  • [36] Glucagon-like peptide-1 receptor agonist-based agents and weight loss composition: Filling the gaps
    Dubin, Robert L.
    Heymsfield, Steven B.
    Ravussin, Eric
    Greenway, Frank L.
    DIABETES OBESITY & METABOLISM, 2024, 26 (12): : 5503 - 5518
  • [37] Is it Time to Expand Glucagon-like Peptide-1 Receptor Agonist Use for Weight Loss in Patients Without Diabetes?
    Updike, Wendy H.
    Pane, Olivia
    Franks, Rachel
    Saber, Faizah
    Abdeen, Farah
    Balazy, Derek D.
    Carris, Nicholas W.
    DRUGS, 2021, 81 (08) : 881 - 893
  • [38] Effects of glucagon-like peptide-1 on appetite and weight: preclinical data and clinical studies
    Sesti, Giorgio
    GIORNALE ITALIANO DI CARDIOLOGIA, 2011, 12 (12) : 10S - 16S
  • [39] Long-term management of type 2 diabetes with glucagon-like peptide-1 receptor agonists
    Courtney, Hamish
    Nayar, Rahul
    Rajeswaran, Chinnadorai
    Jandhyala, Ravi
    DIABETES METABOLIC SYNDROME AND OBESITY, 2017, 10 : 79 - 87
  • [40] Glucagon-like peptide-1 receptors in the brain: controlling food intake and body weight
    Baggio, Laurie L.
    Drucker, Daniel J.
    JOURNAL OF CLINICAL INVESTIGATION, 2014, 124 (10): : 4223 - 4226
12345